Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-006235

Chief Accounting Officer bought 2,500 shares at $1.14 ($2,850)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lerner Neil Chief Accounting Officer 2026-09-24 Purchase +2,500 $1.14 $2,850 400,000 D
Open-market purchases · 2,500 sh · avg $1.14 · $2,850
Loading xslF345X06/ownership.xml…